ALPHA9 THERANOSTICS
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.
ALPHA9 THERANOSTICS
Social Links:
Industry:
Biotechnology Medical Product Research
Founded:
2019-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.alpha9tx.com
Total Employee:
11+
Status:
Active
Contact:
778-231-2500
Email Addresses:
[email protected]
Total Funding:
84.02 M USD
Technology used in webpage:
Amazon Cloudflare Hosting Person Schema Gravatar Profiles
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Generate Biomedicines
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Life Sciences
Frazier Life Sciences investment in Series B - Alpha9 Theranostics
Nextech Invest
Nextech Invest investment in Series B - Alpha9 Theranostics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - Alpha9 Theranostics
Longitude Capital
Longitude Capital investment in Series B - Alpha9 Theranostics
Quark Venture
Quark Venture investment in Series B - Alpha9 Theranostics
Samsara BioCapital
Samsara BioCapital investment in Series B - Alpha9 Theranostics
Longitude Capital
Longitude Capital investment in Series A - Alpha9 Theranostics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series A - Alpha9 Theranostics
WUTIF
WUTIF investment in Seed Round - Alpha9 Theranostics
Official Site Inspections
http://www.alpha9tx.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alpha9 Theranostics"
Alpha9 Theranostics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 778-231-2500 Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.See details»
Alpha-9 Oncology | Radiopharmaceuticals | Cancer …
Through peptide engineering and iterative design, Alpha9 Oncology creates highly selective, potent radiopharmaceuticals for cancer patients.See details»
Alpha-9 Oncology, Inc. - Life Sciences British Columbia
Oct 24, 2024 Website www.alpha9tx.com; Email [email protected]; Address 27 East 7th Ave, Suite 300 Vancouver, BC V5T 1M4; Leadership Contact David Hirsch, CEO; Follow us: …See details»
Animal Technician, Alpha-9 Theranostics, Vancouver, BC.
As a start-up organization, we value team members eager to make an impact and grow with us professionally. We are seeking an individual who enjoys multi-tasking and has the willingness …See details»
Alpha-9 Oncology - LinkedIn
Alpha-9 Oncology | 7,355 followers on LinkedIn. Harnessing the power of radiopharmaceuticals to realize more effective treatments for people living with cancer | Alpha-9 Oncology is a clinical stage, radiopharmaceutical company …See details»
Alpha-9 Theranostics Announces $11 Million Series A ... - Alpha-9 …
Apr 28, 2021 VANCOUVER, British Columbia, April 28, 2021 — Alpha-9 Theranostics Inc. announced today an $11 million Series A financing to advance a portfolio of novel …See details»
Alpha-9 Theranostics Announces $11 Million Series A
Apr 28, 2021 For more information, please visit www.alpha9tx.com. About Longitude Capital. Longitude Capital is a leading healthcare venture capital firm that invests in transformative …See details»
Alpha-9 Oncology - LinkedIn
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of ...See details»
Alpha-9 Theranostics Announces $11 Million Series A Financing to ...
Apr 28, 2021 VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) -- Alpha-9 Theranostics Inc. announced today an $11 million Series A financing to advance a portfolio of …See details»
Alpha-9 Theranostics Announces Oversubscribed $75 ... - Alpha-9 …
Dec 14, 2022 Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers. For …See details»
Alpha-9 Theranostics Announces Oversubscribed $75 …
Dec 14, 2022 For more information, please visit www.alpha9tx.com. SOURCE Alpha-9 Theranostics Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media ...See details»
Alpha-9 Theranostics Announces $11 Million Series A ... - BioSpace
Apr 28, 2021 Alpha-9 Theranostics Inc. announced today an $11 million Series A financing to advance a portfolio of novel radiotherapeutics and diagnostics. Longitude Capital led the …See details»
ALPHA-9 THERANOSTICS APPOINTS SIMON PIMSTONE
May 15th, 2020, Vancouver, Canada: Alpha-9 Theranostics Inc. today announced that it has appointed two senior independent Non-Executive Directors to its Board. Appointed are: Simon …See details»
Alpha-9 Theranostics Strengthens its Scientific Expertise with Key ...
Mar 7, 2023 For more information, please visit www.alpha9tx.com. SOURCE Alpha-9 Theranostics Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? …See details»
Alpha-9 Theranostics Announces Oversubscribed $75 Million …
Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers. For more …See details»
Alpha-9 Theranostics Announces Oversubscribed $75 Million
Dec 14, 2022 Alpha-9 Theranostics Inc., a clinical stage company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment …See details»
Alpha-9 Theranostics Strengthens its Scientific ... - Alpha-9 Oncology
Mar 7, 2023 Dr. Jutta Wanner to lead R&D discovery efforts and support the continued expansion of Alpha-9’s differentiated radiopharmaceutical pipeline Dr. Jason Lewis and Dr. …See details»
Alpha-9 Theranostics Announces $11 Million Series A Financing to ...
Apr 28, 2021 For more information, please visit www.alpha9tx.com. About Longitude Capital Longitude Capital is a leading healthcare venture capital firm that invests in transformative …See details»
First Patient Dosed with A9T-1101 First Product Candidate in …
June 16, 2020, Vancouver, Canada: Alpha-9 Theranostics Inc, a radiopharmaceutical company developing unique technology for imaging and treatment of metastatic cancer, today …See details»
Alpha-9 Theranostics Announces Successful Completion of Phase …
October 30th, 2020, Vancouver, Canada: Alpha-9 Theranostics Inc. TM, a radiopharmaceutical company developing unique technology for imaging and treatment of metastatic cancer, today …See details»